Adrenal-pituitary responsiveness during therapy with an oral contraceptive.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000324:Adrenocorticotropic Hormone; D000328:Adult; D003276:Contraceptives, Oral / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008656:Mestranol / Q000494:pharmacology*; D008797:Metyrapone; D009640:Norethindrone / Q000494:pharmacology*; D010912:Pituitary-Adrenal Function Tests; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D013312:Stress, Physiological
D015065:17-Hydroxycorticosteroids; D003276:Contraceptives, Oral; D000324:Adrenocorticotropic Hormone; D008656:Mestranol; D009640:Norethindrone; D008797:Metyrapone